Step 1 topics → Psychiatry → Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder (GAD)

USMLE Step 1 trap: Confuses GAD's 6-month duration requirement with shorter mood disorder thresholds. GAD requires excessive worry about multiple domains occurring more days than not for at least 6 months.

Generalized Anxiety Disorder (GAD) is a chronic anxiety condition defined by excessive, uncontrollable worry across multiple life domains, and USMLE Step 1 loves it because it sits at the intersection of diagnosis, pharmacology, and differential diagnosis. The worry is pervasive, hard to control, and accompanied by physical and cognitive symptoms like restlessness, fatigue, poor concentration, muscle tension, and sleep disturbance. At least 3 of these 6 associated symptoms are required (1 suffices in children), and the whole picture must persist for at least 6 months.

The exam tests GAD from several angles. Criterion-based questions give you a vignette and ask you to identify what makes this GAD vs. normal stress vs. another anxiety disorder. Pharmacology questions target the mechanism and timeline of buspirone, or ask you to choose between SSRIs, SNRIs, buspirone, and benzodiazepines for different clinical scenarios. Passage-based questions may embed a GAD patient in a longer case and require you to extract what makes the anxiety pathological rather than situational.

What trips students up most is the duration threshold and the role of buspirone. GAD's 6-month requirement is frequently confused with the 2-week criterion for MDD — a classic trap on USMLE Step 1. Buspirone is another high-yield pitfall: students assume it works like a benzo because it's used for anxiety, but it has a 2–4 week delayed onset and zero utility for acute relief. Nail these distinctions and you'll handle the majority of GAD questions cleanly.

From real student decks
43%have cards covering this topic
27%have mature cards

Common misconceptions

Common mistake
Wrong: GAD requires only 2 weeks of excessive worry, similar to MDD's duration threshold.
Right: GAD requires excessive worry about multiple domains occurring more days than not for at least 6 months.
GAD requires 6 months of excessive worry — not 2 weeks. The 2-week threshold belongs to major depressive disorder, and confusing these two is a classic Step 1 trap. If a vignette describes someone who has been worrying excessively for 3 weeks, GAD is not the diagnosis regardless of how many symptoms are present. The 6-month criterion reflects GAD's nature as a chronic, trait-like condition rather than an acute or episodic one.
Common mistake
Wrong: Buspirone provides rapid anxiolytic relief similar to benzodiazepines.
Right: Buspirone has a delayed onset of 2–4 weeks and is not effective for acute anxiety; it is suitable only for chronic GAD management.
Buspirone is not a fast-acting anxiolytic — it takes 2–4 weeks to reach therapeutic effect, similar to SSRIs. It works via partial agonism at 5-HT1A receptors and has no GABAergic activity, so it produces no immediate sedation or relief. If a patient needs rapid symptom control (e.g., situational acute anxiety), buspirone is the wrong choice. It is appropriate only for chronic GAD management in patients who can wait for a delayed response.
Common mistake
Wrong: Benzodiazepines are appropriate first-line long-term treatment for GAD.
Right: SSRIs and SNRIs are first-line for GAD; benzodiazepines may be used short-term for acute relief but carry risks of dependence and are not recommended for long-term use.
SSRIs and SNRIs are the actual first-line long-term treatment for GAD — not benzodiazepines. Benzodiazepines work quickly and do reduce anxiety, but their risks (dependence, tolerance, withdrawal, cognitive blunting) make them unsuitable for the long-term management of a chronic condition like GAD. They may be used short-term to bridge a patient while waiting for an SSRI to kick in, but selecting a benzo as the definitive long-term treatment is a high-yield wrong answer on USMLE Step 1.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the full diagnostic criteria for GAD: excessive worry about multiple domains occurring more days than not for at least 6 months, with at least 3 of 6 associated symptoms (restlessness, fatigue, poor concentration, irritability, muscle tension, sleep disturbance) causing significant impairment.
  2. Know the first-line pharmacologic treatment for GAD (SSRIs and SNRIs), where buspirone fits (chronic GAD, not acute), and why benzodiazepines are not appropriate for long-term management despite being commonly used short-term.
  3. Be able to distinguish GAD from normal worry: pathological anxiety in GAD is excessive relative to the situation, difficult to control, crosses multiple life domains, and persists for 6+ months with functional impairment — normal worry is proportionate, time-limited, and doesn't meet these thresholds.

Can you avoid these mistakes?

A 34-year-old woman presents with excessive worry about her finances, her children's health, and her job performance for the past 8 months. She reports muscle tension, poor sleep, and difficulty concentrating. She says the worry feels uncontrollable. What is the minimum number of associated symptoms required to diagnose GAD, and does she meet the duration threshold?
A patient with newly diagnosed GAD asks if they can take something that 'works right away' for their anxiety. You consider buspirone. Is this appropriate, and why or why not? What would you use instead if immediate relief is the priority?
A vignette describes a 28-year-old man who has been anxious about multiple topics for 3 weeks following a job loss. He has restlessness, fatigue, and poor concentration. A classmate says this is GAD. What is wrong with that diagnosis, and what is the most likely explanation for his symptoms?
You are choosing between an SSRI, buspirone, and a benzodiazepine for long-term management of a patient with confirmed GAD. Rank these in terms of appropriateness for chronic use and explain the role each plays in GAD treatment.

Related topics

Major Depressive Disorder (MDD) Persistent Depressive Disorder (Dysthymia) Bipolar I Disorder Bipolar II Disorder

See how your Anki deck covers this topic.

Upload your deck for a free audit →